Filing Details
- Accession Number:
- 0001235802-19-000133
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-18 16:22:35
- Reporting Period:
- 2019-11-15
- Accepted Time:
- 2019-11-18 16:22:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1492658 | Wright Medical Group N.v. | WMGI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1317960 | James Lightman | 1023 Cherry Road Memphis TN 38117 | Svp, Gen'l Counsel & Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, Par Value Eur 0.03 Per Share | Acquisiton | 2019-11-15 | 33,504 | $15.75 | 95,079 | No | 4 | M | Direct | |
| Ordinary Shares, Par Value Eur 0.03 Per Share | Acquisiton | 2019-11-15 | 566 | $17.70 | 95,645 | No | 4 | M | Direct | |
| Ordinary Shares, Par Value Eur 0.03 Per Share | Acquisiton | 2019-11-15 | 7,444 | $20.75 | 103,089 | No | 4 | M | Direct | |
| Ordinary Shares, Par Value Eur 0.03 Per Share | Acquisiton | 2019-11-15 | 1,999 | $22.55 | 105,088 | No | 4 | M | Direct | |
| Ordinary Shares, Par Value Eur 0.03 Per Share | Acquisiton | 2019-11-15 | 11,099 | $23.93 | 116,187 | No | 4 | M | Direct | |
| Ordinary Shares, Par Value Eur 0.03 Per Share | Acquisiton | 2019-11-15 | 9,086 | $29.06 | 125,273 | No | 4 | M | Direct | |
| Ordinary Shares, Par Value Eur 0.03 Per Share | Acquisiton | 2019-11-15 | 78,785 | $20.62 | 204,058 | No | 4 | M | Direct | |
| Ordinary Shares, Par Value Eur 0.03 Per Share | Acquisiton | 2019-11-15 | 28,944 | $21.24 | 233,002 | No | 4 | M | Direct | |
| Ordinary Shares, Par Value Eur 0.03 Per Share | Acquisiton | 2019-11-15 | 10,157 | $27.86 | 243,159 | No | 4 | M | Direct | |
| Ordinary Shares, Par Value Eur 0.03 Per Share | Acquisiton | 2019-11-15 | 7,284 | $24.49 | 250,443 | No | 4 | M | Direct | |
| Ordinary Shares, Par Value Eur 0.03 Per Share | Disposition | 2019-11-15 | 188,868 | $29.45 | 61,575 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (right to buy) | Disposition | 2019-11-15 | 33,504 | $0.00 | 33,504 | $15.75 |
| Ordinary Shares | Stock Option (right to buy) | Disposition | 2019-11-15 | 566 | $0.00 | 566 | $17.70 |
| Ordinary Shares | Stock Option (right to buy) | Disposition | 2019-11-15 | 7,444 | $0.00 | 7,444 | $20.75 |
| Ordinary Shares | Stock Option (right to buy) | Disposition | 2019-11-15 | 1,999 | $0.00 | 1,999 | $22.55 |
| Ordinary Shares | Stock Option (right to buy) | Disposition | 2019-11-15 | 11,099 | $0.00 | 11,099 | $23.93 |
| Ordinary Shares | Stock Option (right to buy) | Disposition | 2019-11-15 | 9,086 | $0.00 | 9,086 | $29.06 |
| Ordinary Shares | Stock Option (right to buy) | Disposition | 2019-11-15 | 78,785 | $0.00 | 78,785 | $20.62 |
| Ordinary Shares | Stock Option (right to buy) | Disposition | 2019-11-15 | 28,944 | $0.00 | 28,944 | $21.24 |
| Ordinary Shares | Stock Option (right to buy) | Disposition | 2019-11-15 | 10,157 | $0.00 | 10,157 | $27.86 |
| Ordinary Shares | Stock Option (right to buy) | Disposition | 2019-11-15 | 7,284 | $0.00 | 7,284 | $24.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-12-29 | No | 4 | M | Direct | |
| 0 | 2022-04-16 | No | 4 | M | Direct | |
| 0 | 2022-05-09 | No | 4 | M | Direct | |
| 0 | 2023-04-17 | No | 4 | M | Direct | |
| 0 | 2023-05-14 | No | 4 | M | Direct | |
| 0 | 2024-05-13 | No | 4 | M | Direct | |
| 0 | 2025-10-13 | No | 4 | M | Direct | |
| 6,720 | 2026-07-19 | No | 4 | M | Direct | |
| 7,917 | 2027-07-25 | No | 4 | M | Direct | |
| 16,035 | 2028-07-24 | No | 4 | M | Direct |
Footnotes
- Exercise and sale of vested stock options in connection with 280G tax planning.
- Includes 3,103 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 9,580 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 10,124 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.40 to $29.495, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
- This option has fully vested.
- This option vested with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
- This option vested with respect to 25% of the shares on July 25, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
- This option vested with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
Billionaire Hedge Funds
